Integrated BioPharma (OTCMKTS:INBP) Trading Up 1.6% – Here’s Why

Integrated BioPharma Inc. (OTCMKTS:INBP) traded up 1.6% during mid-day trading on Monday . The stock traded as high as $0.3220 and last traded at $0.32. 24,725 shares were traded during trading, an increase of 32% from the average session volume of 18,668 shares. The stock had previously closed at $0.3150.

Integrated BioPharma Stock Performance

The company has a market cap of $9.91 million, a price-to-earnings ratio of 16.01 and a beta of 0.95. The company has a current ratio of 4.42, a quick ratio of 2.21 and a debt-to-equity ratio of 0.01. The stock’s fifty day simple moving average is $0.30 and its 200 day simple moving average is $0.30.

Integrated BioPharma (OTCMKTS:INBP) last announced its quarterly earnings data on Tuesday, September 23rd. The company reported ($0.01) EPS for the quarter. Integrated BioPharma had a return on equity of 4.04% and a net margin of 1.49%.The company had revenue of $14.18 million for the quarter.

Integrated BioPharma Company Profile

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.